Clincosm LogoSign in Get a demo

chronic myelogenous leukemia

Showing NaN - NaN of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Asciminib single agent
  • +5 more
  • Ann Arbor, Michigan
  • +49 more
Jan 26, 2023

Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +18 more
Jan 19, 2023

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib followed by treatment-free)

Active, not recruiting
Has Results
  • Chronic Myelogenous Leukemia
  • Nilotinib followed by treatment-free
  • Fort Myers, Florida
  • +113 more
Apr 25, 2022

Biology of Long-Term Late Effects Following Hematopoietic Cell

Active, not recruiting
  • Acute Lymphoblastic Leukemia/Lymphoma
  • +4 more
    • Scottsdale, Arizona
    • +31 more
    Mar 8, 2022

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States

    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • +4 more
    • Single Umbilical Cord Blood Unit Transplant
    • +6 more
    • Birmingham, Alabama
    • +37 more
    Oct 13, 2021

    Chronic Myelogenous Leukemia Trial in Canada, United States (Nilotinib)

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • Fayetteville, Arkansas
    • +22 more
    Jun 29, 2021

    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • +3 more
    • Duarte, California
    • +100 more
    Jun 8, 2021

    Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),

    Completed
    Has Results
    • Acute Leukemia
    • +8 more
    • Tacrolimus (ARM with Methotrexate)
    • +7 more
    • Duarte, California
    • +29 more
    Jan 2, 2019

    Chronic Myelogenous Leukemia, Hematologic Malignancies Trial in United States (Ponatinib)

    Completed
    • Chronic Myelogenous Leukemia
    • Hematologic Malignancies
    • San Francisco, California
    • +4 more
    May 15, 2018

    Chronic Myelogenous Leukemia Trial in France, United States (Nexavar (Sorafenib, BAY43-9006))

    Completed
    • Chronic Myelogenous Leukemia
    • Nexavar (Sorafenib, BAY43-9006)
    • Portland, Oregon
    • +3 more
    Dec 18, 2014

    Chronic Myelogenous Leukemia Trial in Worldwide (imatinib mesilate, interferon-alpha (INF-a), cytarabine (ARA-C))

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • imatinib mesilate
    • +2 more
    • Birmingham, Alabama
    • +162 more
    Aug 7, 2013

    Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • Birmingham, Alabama
    • +69 more
    Apr 13, 2011